- Clinical Trials
- April 2025
- 60 Pages
Global
From €1090EUR$1,250USD£948GBP
- Report
- January 2026
- 196 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- August 2025
- 180 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- September 2025
- 250 Pages
Global
From €3915EUR$4,490USD£3,404GBP
- Report
- April 2025
- 175 Pages
Global
From €3915EUR$4,490USD£3,404GBP
- Report
- February 2026
- 291 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Report
- February 2026
- 191 Pages
Global
From €5101EUR$5,850USD£4,435GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1090EUR$1,250USD£948GBP
- Report
- September 2025
- 112 Pages
Global
From €3500EUR$4,300USD£3,150GBP
- Report
- October 2025
- 160 Pages
Global
From €3444EUR$3,950USD£2,995GBP
- Report
- October 2025
- 160 Pages
Global
From €3444EUR$3,950USD£2,995GBP
- Report
- July 2025
- 155 Pages
Global
From €4054EUR$4,650USD£3,526GBP
- Report
- May 2025
- 150 Pages
Global
From €5188EUR$5,950USD£4,511GBP
- Report
- January 2026
- 194 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- January 2026
- 199 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- January 2026
- 193 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- January 2026
- 191 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- January 2026
- 184 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- January 2026
- 193 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- August 2025
- 180 Pages
Global
From €3434EUR$3,939USD£2,986GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more